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Abstract: Background and Objectives: The socioeconomic working group of the European myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS) Research Network (EUROMENE) has con-
ducted a review of the literature pertaining to GPs’ knowledge and understanding of ME/CFS;
Materials and Methods: A MEDLINE search was carried out. The papers identified were reviewed
following the synthesis without meta-analysis (SWiM) methodology, and were classified according to
the focus of the enquiry (patients, GPs, database and medical record studies, evaluation of a training
programme, and overview papers), and whether they were quantitative or qualitative in nature;
Results: Thirty-three papers were identified in the MEDLINE search. The quantitative surveys of GPs
demonstrated that a third to a half of all GPs did not accept ME/CFS as a genuine clinical entity and,
even when they did, they lacked confidence in diagnosing or managing it. It should be noted, though,
that these papers were mostly from the United Kingdom. Patient surveys indicated that a similar
proportion of patients was dissatisfied with the primary medical care they had received. These
findings were consistent with the findings of the qualitative studies that were examined, and have
changed little over several decades; Conclusions: Disbelief and lack of knowledge and understanding
of ME/CFS among GPs is widespread, and the resultant diagnostic delays constitute a risk factor
for severe and prolonged disease. Failure to diagnose ME/CFS renders problematic attempts to
determine its prevalence, and hence its economic impact.
Keywords: ME/CFS; myalgic encephalomyelitis; chronic fatigue syndrome; primary care; GP
knowledge and understanding
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1. Introduction
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a poorly under-
stood, serious, complex, multi-system disorder, characterized by symptoms lasting at least
six months, with severe incapacitating fatigue not alleviated by rest, and other symptoms,
many autonomic or cognitive in nature, including cognitive dysfunction, sleep distur-
bances, muscle pain, and post-exertional malaise, which lead to marked reductions in
functional activity and quality of life [1–3]. Symptomatology, severity and disease progres-
sion are all very variable. ME/CFS is most common between the ages of 20 to 50 years, but
it can affect all age groups. Around three quarters of patients are female [4–6]. There are
no Europe-wide prevalence data, but there is a commonly held belief that there are some
250,000 sufferers in the U.K. [7]. If this is correct, there may be some two million patients in
Europe as a whole.
The European ME/CFS Research Network (EUROMENE) was established to promote
collaborative research on the condition across Europe. It is currently in receipt of EU funding
from the Collaboration on Science and Technology Association (COST, https://www.cost.eu)
to support network activities. It seeks to review the current state of the art and to identify
gaps in knowledge of ME/CFS. EUROMENE also aims to shed light on the overall burden of
disease, and also to investigate possible biomarkers, diagnosis and treatment [8].
Previous work by the socioeconomic working group of EUROMENE identified
widespread failure by GPs to diagnose ME/CFS as an important factor contributing to
underestimation of the incidence and prevalence of the illness, and hence of its economic
impact [9]. The group conducted a pilot survey among EUROMENE participants to assess
the position regarding GP diagnoses of ME/CFS [10]. The survey findings suggested
that under-diagnosis in primary care was a Europe-wide problem, and that estimates
of the public health burden of the illness, even where these exist, are therefore likely to
underestimate substantially its true prevalence.
A systematic review of qualitative studies published in 2013 and concerned with
barriers to the diagnosis and management of CFS/ME in primary care identified 21 studies.
This review demonstrated a limited understanding of ME/CFS by GPs [11]. We conducted
a comprehensive literature review with the aim of assessing whether primary care doctors’
awareness, understanding and acceptance of ME/CFS as a disease has changed in the
intervening years.
2. Materials and Methods
A MEDLINE search was carried out, covering the period from 1946 until 20 August
2020. The inclusion criteria were focuses on general practice, family practice, primary care
or primary health care, and myalgic encephalomyelitis or chronic fatigue syndrome (in-
cluding ME/CFS, CFS/ME, and post-viral fatigue syndrome). Exclusions were papers not
addressing GP attitudes, knowledge or understanding of ME/CFS or any of its synonyms.
The papers were sorted into categories following the synthesis without meta-analysis
(SWiM) methodology. Categories were defined on the basis of the focus of the enquiry
(patients, GPs, database and medical record studies, evaluation of a training programme, and
overview papers), and whether the studies were quantitative or qualitative in nature. These
are summarised in Table 1 below. One of the papers was the review referred to above [11].
Table 1. Search Strategy.
Step Description No. Records
1 General Practice or family practice 75,004
2 limit 1 to abstracts 35,740
3 Primary care, or primary health care 133,124
4 limit 3 to abstracts 104,892
5 2 or 4 129,775
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Table 1. Cont.
Step Description No. Records
6 Myalgic encephalomyelitis, or fatigue syndrome, chronic 5606
7 limit 6 to abstracts 3936
8 5 and 7 176
9 After exclusions (because not conforming to inclusion criteria) 33




The search strategy and its outcomes are summarised in Table 1 and Figure 1 below:
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At step 9, 143 papers were excluded, either because the focus was not primary care,
or because they were not about ME/CFS, or because, although they did concern ME/CFS
in primary care, they did not address knowledge or understanding of the condition. The
papers identified were extremely heterogeneous with respect to the populations studied,
research questions addressed, and methodologies followed, as to preclude any form of
meta- synthesis or meta-analysis. Consequently, the synthesis without meta-analysis
(SWiM) methodology, which was developed specifically to ensure an adequate standard of
review in such circumstances, was utilised [12].
3.1.2. Papers Identified
The papers identified in the MEDLINE search were considered in detail within the
categories identified in Table 2.
Table 2. Summary of papers identified.





Medical record review—quantitative 1
Evaluation of training programme—quantitative 1
GP studies—qualitative 6
Patient studies—qualitative 9
Overview papers on myalgic encephalomyelitis/chronic fatigue
syndrome (ME/CFS) 4
* Note that the total is greater than the number identified in the MEDLINE search, because some qualitative
papers are included in more than one category.
3.2. Quantitative Studies
3.2.1. Surveys of GPs
Seven papers were identified. Saidi and Haines (2006) distributed a postal ques-
tionnaire to GPs throughout the U.K., to assess the proportion of practices with children
diagnosed with ME/CFS [13]. Of the 112 practices contacted, 62 (55%) had diagnosed
children or adolescents with chronic fatigue.
For each of the other six studies, the outcome metric was the proportion of GP
respondents to questionnaires who recognised ME/CFS as a genuine clinical entity, and
these are summarised in Table 3. Three of these studied GPs were in different parts of
the U.K., namely, South Wales [14], Scotland [15] and south-west England [16], while
the other papers were from Australia [17], the Netherlands [18] and Ireland [19]. The
Australian study reported that 31% of GPs surveyed did not accept ME/CFS as a distinct
syndrome [17], but we lacked a full text of this paper.
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Table 3. Acceptance in general practice of ME/CFS as a genuine clinical entity.









McNamara I. [15] 1991 Scotland 178 71
Response to question as to
whether respondent
accepted the existence of
chronic fatigue syndrome,




K et al. [19]
1997 Ireland 118 58
Response to question: ‘Do
you accept CFS as a distinct
clinical entity?’, requiring




Swanink CM et al.
[18]
1999 Netherlands 3881 99
Inferred from number of
invitees who cited disbelief
in the syndrome as their
reason for non-response
Thomas MA,
Smith AP. [14] 2005 South Wales 45 56
Proportion of respondents
agreeing that the syndrome
actually exists (specific
question not reported)
Bowen J, Pheby D,
Charlett A,
McNulty C. [16]
2005 South-westEngland 811 72
Responses agreeing or
strongly agreeing to
proposition via a 5-point
Likert scale
In the Dutch study [18] respondents were not specifically asked whether they accepted
the existence of ME/CFS as a genuine clinical entity, and the proportion of GPs who
reported that they did not accept ME/CFS as a genuine clinical entity was inferred from
the number of those contacted who indicated, via a free text response, that this was their
opinion. However, 73% of respondents reported that they had at least one patient with
chronic fatigue syndrome, and 83% that they had at least one patient with post-viral fatigue
syndrome.
The heterogeneous nature of populations studied, and the research methodologies
utilised precluded a formal meta-analysis, but for comparison purposes we have calculated
95% confidence intervals for the British and Irish studies which specifically enquired about
the acceptance of ME/CFS as a genuine diagnosis. The higher levels of acceptance of
ME/CFS in Scotland and south-west England may demonstrate the impact of secondary
referral facilities and active programmes of GP education in those areas. The results are
itemised in Table 4.
There were additional findings of relevance in the studies examined. Bowen et al. [16]
found that only 52% of respondents expressed confidence in their ability to diagnose the
condition, and 59% in their ability to manage it. Sixty-eight percent of respondents to
the study in South Wales had diagnosed the condition [14]. In the Irish study, 78% of
respondents had patients with chronic debilitating fatigue in their practices [19].
These studies were published over a fourteen-year period, and are consistent in
demonstrating that a substantial proportion of GPs, which changed little over that time,
did not accept ME/CFS as a genuine clinical entity.
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Table 4. Acceptance by GPs of ME/CFS—summary statistics.
Reference





McNamara [15] 127/178 71.0 33.0–47.2
Fitzgibbon et al. [19] 68/118 58.0 48.6–66.2
Thomas and Smith [14] 25/45 56.0 41.1–69.1
Bowen et al. [16] 584/811 72.0 68.8–75.0
TOTAL 804/1152 69.8 67.1–72.4
3.2.2. Surveys of ME/CFS Patients
Seven papers were identified in this section, but three could not be included in the
overall comparative analysis, one for the lack of a full text, and the others for absence of
relevant numerical information. The first of these, a Belgian study of 177 patients with
different GPs, attending a tertiary clinic, found that only 35% of respondents thought
that their GPs had experience of the condition, and only 23% felt their GP had sufficient
knowledge to treat it [20]. Another Belgian study of 155 patients with ME/CFS recruited
via primary care practitioners reported that 43% of subjects self-assessed as having interper-
sonal problems with their GPs. A disparity with physician assessments was asserted, and
the authors concluded that this disparity had to be seen in the context of previous research,
demonstrating that patients with ME/CFS tended to feel misunderstood and disrespected.
However, this disparity was not reported numerically [21]. Finally, a French report on 231
participants in a clinical trial undertaken in general practice found a tendency in primary
care to attribute fatigue to somatic causes in cases with more reported symptoms. They
attributed this to a predilection not to entertain somatic explanations of mild or moderate
fatigue, but this could not be quantified from the information presented [22].
The remaining four papers are summarised in Table 5. Three of them, from Norway,
are interrelated [23–25], and it can be noted that, although the outcome measures in these
studies were not precisely the same as that in an American study by Jason et al. [26], and
the populations studied and the modes of selection of participants were different, the
proportions of respondents expressing reservations about aspects of the quality of primary
care were similar in magnitude.
Table 5. Patients’ opinions about GP care of people with ME/CFS.
Authors Year ofPublication
Location Sample Size Source of
Recruitment
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Table 5. Cont.
Authors Year ofPublication
Location Sample Size Source of
Recruitment
Principal Relevant Outcome Measure
Description Numerical Value
Hansen AH;




















large extent or to




3.2.3. Other Quantitative Studies
Other quantitative studies identified included two database studies [27,28] a review
of medical records [29], and an evaluation of a training programme [30].
Gallagher et al., [27] in an analysis of data from the U.K. General Practice Research
Database (now the Clinical Practice Research Datalink), found that, between 1990 and 2001,
there was a marked decline in diagnoses of post-viral fatigue syndrome, paralleled by
increases in diagnoses of ME/CFS and fibromyalgia, suggesting that diagnostic fashion
has a significant part to play in the allocation of diagnostic labels by GPs. A study based
on the Norwegian Patient Register found that there were substantial delays in the primary
care diagnosis of ME/CFS in children and adolescents. Three-quarters of those patients
identified were initially diagnosed with weakness/general tiredness, and for nearly half of
them the interval between this initial diagnosis and the definitive diagnosis of ME/CFS
was over a year. A comparison with diagnoses of type 1 diabetes mellitus found that only
3.5% of patients were initially diagnosed with weakness/general tiredness, and there was
no comparable diagnostic delay [28].
A comparative study of the primary care prevalence of ME/CFS in Sao Paolo and
London was carried out by means of a review of medical records [29]. The overall preva-
lence of chronic fatigue syndrome plus unexplained chronic fatigue was similar in both
countries. However, a slightly higher prevalence of chronic fatigue syndrome was appar-
ent among the U.K. patients. The authors attributed this to a cultural factor, namely, a
relative lack of recognition of chronic fatigue syndrome among Brazilian doctors, but in
fact the difference in prevalence of CFS between the Brazilian and English samples was not
statistically significant (prevalence: Brazil 1.6%; U.K. 2.1%. p = 0.09).
An American study evaluated a series of five two-day “Train-the-Trainer” workshop
training programmes directed towards increasing ME/CFS understanding in primary
care [30]. There were marked improvements in both knowledge and self-efficacy, leading to
increased confidence in making the diagnosis, but the point was made that the participants
were self-selected.
3.3. Qualitative Studies
3.3.1. Studies of GPs
We identified six papers reporting qualitative studies involving GPs dating from 1993
to 2016. The earliest was from New Zealand [31], and the others were all from the U.K., the
most recent four coming from the same team based in north-west England [32–36]. The
papers are summarised in Table 6:
All the papers reviewed were consistent in concluding that there were substantial
gaps in levels of knowledge and understanding of ME/CFS.
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3.3.2. Studies of Patients
Nine papers were identified in this category. Our detailed analysis is summarised in
Table 7.
It will be noted that the methodologies followed were extremely heterogeneous, pre-
cluding any sort of meta-synthesis, but the overall conclusions in all cases were very similar.
Concern was expressed in most cases about the lack of legitimation of the condition, and
many GPs were seen as being unsympathetic and lacking in knowledge of the condition,
and therefore not a good source of advice. By contrast, a good rapport with the doctor was
seen to be very positive, though frequently missing.
3.4. Overview Papers
The final category identified in this analysis was of a small number of publications
which made reference to problems of GP knowledge and understanding of the condition,
but presented no empirical research. Bansal wrote a wide-ranging paper centred on the
use of a simplified scoring system for the diagnosis of ME/CFS in general practice, in
which he described ME/CFS as poorly understood, and refers to disagreements concerning
investigation and management [37]. Wearden and Chew-Graham reviewed the evidence
on the primary care treatment of ME/CFS. They acknowledged that some primary care
physicians find ME/CFS hard to diagnose, but argued that early diagnosis and coherent
explanation of symptoms would be of benefit [38]. Murdoch produced a straightforward,
easy-to-follow guide to the diagnosis and care of patients with ME/CFS, via an illustrative
clinical scenario, and asserted that ME/CFS is best managed by the patient’s GP in a
primary care setting [39]. Campion, in a letter to the British Journal of General Practice,
stated that the biopsychosocial model of ME/CFS had caused disagreement between
doctors and patients, and that doctors should respect patients, and, given our ignorance of
the precise causes of the condition, show humility [40].
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Table 6. Papers reporting qualitative studies of GPs’ knowledge and understanding of ME/CFS.
Authors Year ofPublication Location Methodology GP Sample Size Relevant Outcome Measures Findings
Denz-Penhey H,
Murdoch JC [31] 1993 New Zealand
Action research in a
general practice 10





prevention), and service and
delivery mechanisms
The authors concluded that medical
models of illness were unhelpful, and
patients suffered as failure to legitimate
their conditions led to denial of access
to medical care. They wrote: “Doctors
. . . have a weighty bias towards the
biomedical model even when it has
manifestly failed to meet the needs of
our patients.”
Raine R; Carter S; Sensky
T [32] 2004 England
Focus group discussions
of clinical scenarios 46
Thematic analysis of focus
group transcripts, examined
against field notes.
Findings support research indicating
that outcomes are poorer where doctors
and patients disagree. Doctors’ beliefs
could result in negative stereotyping of
patients with CFS, which constituted a
barrier to effective clinical management.
Chew-Graham C;
Dowrick C; Wearden A;








trial (the FINE Trial)
22
Five themes were identified:
defining CFS/ME, excluding
physical causes, potential
harm from the label, the role
of referral and moving on
from making the diagnosis.
There was lack of confidence among
GPs about making the diagnosis and
uncertainty about CFS/ME as a medical
condition. Hence, GPs were reluctant to
make the diagnosis of CFS/ME, with
resultant diagnostic delays and lack of
appropriate primary care.
Hannon K, Peters S,
Fisher L, Riste L,
Wearden A, Lovell K,










with the intention of
developing a training resource
on ME/CFS for primary care.
The GPs had varying degrees of
understanding of ME/CFS; some
questioned whether ME/CFS was a
legitimate illness, and were unaware of
the evidence base. There was concern
about difficulties of referral to
secondary care due to fragmented
services and lack of collaboration.
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Table 6. Cont.
Authors Year ofPublication Location Methodology GP Sample Size Relevant Outcome Measures Findings
Bayliss K; Riste L; Fisher







patients, 2 carers, 9 GPs,





Key themes identified were:






Patients tended to be unwilling to
consult GPs for fatigue, and also
encountered impediments to accessing
primary care. The high turnover of
inner-city GPs may constitute a barrier
to accessing care.
Bayliss K, Riste L, Band
R, Peters S, Wearden A,









GPs’ experience of managing
people with CFS/ME before
participating in the study, and
their opinions on the training
programme.
There was difficulty recruiting GP
practices, for reasons including
scepticism about ME/CFS, the
complexity of managing the condition,
lack of time in a 10 min consultation,
and limited specialist referral options.
Table 7. Qualitative studies of patients’ views of GPs’ knowledge and understanding of ME/CFS.
Authors Year ofPublication Location Methodology
Patient Sample
Size Relevant Outcome Measures Findings
Denz-Penhey H,
Murdoch JC [31] 1993 New Zealand
Action research in a
general practice 10
What patients expected of
their GPs.
Patients primarily sought legitimation,
and acknowledgement of the illness
(i.e., acceptance, diagnosis, support),
symptom control, recommendations
regarding health behaviours, and
relapse prevention. There was much
dissatisfaction with GPs’ perceived
failure to meet patients’ needs.
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Table 7. Cont.
Authors Year ofPublication Location Methodology
Patient Sample
Size Relevant Outcome Measures Findings
Ax S; Gregg VH; Jones D.
[41] 1997 London, U.K.
Semi-structured
interviews 18
Illness beliefs, meaning of the
diagnosis and satisfaction
with medical support.
Most participants found that GP
emotional and informational support
was inadequate, and they felt
unsupported. This was coupled with
the rejection of medical and health
professionals and an increased sense of
self-reliance.
Saltzstein BJ, Wyshak G,
Hubbuch JT, Perry JC
[42]
1998 U.S.A. Semi-structuredinterviews 15
Self-report v. perception of
physician’s prognosis
Improvement in health appeared
associated with early diagnosis and a
physician optimistic about prognosis
Chew-Graham CA;
Cahill G; Dowrick C;







controlled trial (the FINE
Trial)
24





Patients were aware of the risk to their
credibility from GPs who may not have
accepted that ME/CFS even existed as a
genuine diagnosis, and were also aware
of the limitations of many GPs’
knowledge of the condition.
Chew-Graham C; Brooks
J; Wearden A; Dowrick











accepted and believed by the
therapist, their own
acceptance of the diagnosis,
and accepting the model of
illness presented by the
therapist.
Engagement of patients with pragmatic
rehabilitation in primary care depends
on whether they feel accepted and
believed, accept the diagnosis, and have
an illness model consistent with the
treatment.
Gilje AM; Soderlund A;
Malterud K. [45]. 2008 Norway
Questionnaire and
follow-up meeting 12
Exploration of patients’ views
about the impact of negative
opinions held by doctors.
Lack of GP belief in or
acknowledgement of the reality of the
illness can be worse for patients than
the illness itself. Participants wanted
doctors to question, listen and take
them seriously. GPs were perceived as
knowing little about ME/CFS, and
therefore unable to give advice.
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Table 7. Cont.
Authors Year ofPublication Location Methodology
Patient Sample
Size Relevant Outcome Measures Findings
Hannon K, Peters S,
Fisher L, Riste L,
Wearden A, Lovell K,





9 of whom were from
BME communities.
16
Key themes identified were
the need to be believed, the




benefit of consultation, and
the role of carers.
Patients expressed frustration when
GPs challenged the legitimacy of the
condition, and failed to recognise its
seriousness, or how it can affect
articulateness and memory. Patients felt
a need for signposting, but GPs lacked
knowledge of the condition and
relevant contacts.
Bayliss K; Riste L; Fisher







patients, 2 carers, 9 GPs,





Themes raised by patients
included:
GPs’ perceptions;
patients’ lack of awareness of
ME/CFS;
community pressures.
Patients perceived a lack of focus by
GPs on non-specific symptoms, lack of
continuity among city-centre GPs,
negative experiences with GPs (e.g.,
seeing some BME people as ‘work shy’).
BME GPs seen as less likely to diagnose
ME/CFS.
Community pressures include language
barriers; family pressures, e.g., to be a
high achiever; the influence of religion,
so that some would turn to religion or
spiritual healers rather than primary
care. GPs considered unaware of this.
Bayliss K, Riste L, Band
R, Peters S, Wearden A,









The enquiry centres on the
extent of agreement between
patients and GPs about how
and by whom ME/CFS should
be managed in primary care,
what is needed to be done to
achieve collaboration between
patients and GPs, and how the
training programme should be
assessed.
Patients felt that ME/CFS should be
managed within primary care, but
wanted to be believed and to receive a
positive diagnosis. Where this did not
happen, patients disengaged from
primary care, illustrating the tension
between their needs and barriers to care
perceived by GPs, including the
inadequacy of a ten-minute
consultation for such a complex illness.
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4. Discussion
The quantitative surveys of GPs were carried out over a fourteen-year period, and
are consistent in demonstrating that a substantial proportion of GPs, which changed
little over that time, did not accept ME/CFS as a genuine clinical entity. In addition, it
is clear that many GPs, even when they accept that ME/CFS is real, lack confidence in
diagnosing or managing it. There is a similar degree of consistency in the surveys of
patients with clinically confirmed ME/CFS. Despite differences in geographical location,
they again report degrees of criticism of aspects of GP care which are similar in magnitude.
Other reviewed quantitative studies suggested that diagnostic fashion played a part in
GP diagnosis, that there were substantial delays in diagnosing ME/CFS in primary care
in children, and that the problem of lack of recognition of ME/CFS was geographically
widespread despite cultural differences between different countries.
Similarly, the qualitative studies of GPs, despite differences in geographical location
and methodology, were consistent in demonstrating marked gaps in GPs’ knowledge and
the understanding of ME/CFS. The extremely heterogeneous studies of patients all came
to similar conclusions: that there were problems for patients over legitimation of the illness,
and over lack of sympathy and knowledge among GPs. The reviewed overview papers
acknowledged that ME/CFS was poorly understood in primary care, but that ME/CFS
was best managed by GPs, who needed to show respect for patients and humility.
The strengths of the study are firstly that we were able to perform a wide-ranging
review of the literature, including qualitative, quantitative and mix-methods research, from
both the GP and the patient perspectives. Secondly, we were able to take a methodologically
rigorous approach, following the SWiM methodology. The weakness of the study was
that, because of the heterogeneity of the literature identified, we were not able to perform
a systematic review, and we were unable to carry out a meta-synthesis of the qualitative
papers, or a meta-analysis of the quantitative papers. It is also possible that some papers
may have been missed by our search.
The studies of both GPs and patients all point in the same direction. Many doctors
display uncertainty about whether ME/CFS is a real illness, either not having been trained
in it or refusing to recognise ME/CFS as a genuine clinical entity, with consequent delays in
diagnosis and treatment for patients. Patients with ME/CFS, for their part, often experience
suspicion from healthcare professionals and resultant marginalisation, which represents
professional failure, with ethical and practical consequences for care and treatment [46].
There are other pointers in the research literature, in addition to those papers identified in
our MEDLINE search, which lead to the same conclusions. For example, a Dutch study
of the prevalence of ME/CFS-like illness in the working population concluded that such
illness may be under-detected in the working population and perhaps in other populations
as well [47]. An English study assessing the feasibility of a randomised controlled trial of
an early intervention for ME/CFS in primary care concluded that this was not feasible,
partly because of evidence of GPs’ difficulties in diagnosing ME/CFS and managing the
condition [48].
The factors underlying under-ascertainment of ME/CFS are complex and multiple.
The mistaken conclusion [49,50] that an early recorded manifestation of epidemic ME/CFS,
Royal Free disease, was epidemic hysteria [51] has coloured thinking for half a century,
with its insistence on the biopsychosocial hypothesis that ME/CFS can be totally explained
away as being due to faulty illness beliefs combined with deconditioning. This has been
important in creating disbelief and uncertainty among healthcare professionals in respect
of diagnosis, living with ME/CFS, treatment and management, professional values, and
support for people with ME/CFS, with insufficient importance attached to listening skills
and to establishing a therapeutic relationship [52]. Such controversies surrounding the
diagnosis have led to tension between patients and healthcare professionals [53], and
the helplessness many GPs feel because of their lack of knowledge of ME/CFS leads to
avoidance and neglect [54].
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The consequences of under-ascertainment, and the lack of services to treat ME/CFS,
contributes to patient stress and depression, which is frequently associated with fatigue [55].
Diagnostic delay is a risk factor for severe disease (i.e., rendering the patient housebound
or bedbound) [56], and such patients may lie at home without having seen a doctor for
many years. Furthermore, diagnostic failures in primary care affect outcomes adversely; for
example, it has been shown that failure to diagnose primary sleep disorders in individuals
with ME/CFS may be implicated in the development of psychological disturbances [57].
Many of the papers in this review were published some years ago, but there is evidence
in the grey literature that very little has changed. A survey of members of the Oxfordshire
ME supporters’ group in England (OMEGA) in 2012 reported that, of the 56 who responded,
all had been diagnosed with ME/CFS, half of them (28) by a GP. However, only 10 had
seen their GP in the month prior to completing the questionnaire. Only 27% of OMEGA
members surveyed found their GP to be either helpful or most helpful. The report’s
author commented that “listening to the patient, believing what they say and coming to
an accurate diagnosis would seem to be the most basic starting point for any effective
treatment or help. However, this is not the case for many ME/CFS patients. 39% mentioned
lack of diagnosis and belief as the most unhelpful thing”. Uninformed, negative or hostile
attitudes from healthcare professionals are very stressful and detrimental to the health and
well-being of people with ME/CFS, and could deter them from seeking treatment. Patients
had low expectations of their GPs, and frequently failed to receive good advice or effective
symptom control because of a lack of information on the part of GPs. They themselves have
identified this as a problem, although most GPs (93%) recognised ME/CFS as a genuine
clinical entity. Three-quarters (74%) of GPs recognised the need for better information and
training about diagnosis and treatment, and the availability of local services. Uninformed,
negative, or hostile attitudes to people with ME/CFS from healthcare professionals were
very stressful and detrimental to health and well-being, and could deter them from seeking
treatment [58].
An unpublished survey was conducted in 2018 in the U.K. of 44 hospital doctors
attending a regional training event. They completed a questionnaire, the responses to
which showed that 72% did not know how to diagnose ME, while 76% lacked confidence
in dealing with ME patients. Eighty-two percent of respondents believed ME to be at least
in part a psychological or psychosomatic problem, while 39% did not realise that post
exertional malaise is an essential requirement for the diagnosis of ME [59].
Other evidence has been provided in a report from the European Federation of Neu-
rological Associations (EFNA), which published a survey on stigma and neurological
disorder. There were 1373 responses to the survey; 402 of these were received from people
with ME/CFS, many of whom felt stigmatised in their interactions with medical profes-
sionals. A total of 74% felt that a medical professional did not believe the extent or severity
of their symptoms, and the same percentage felt that they did not receive adequate or
appropriate treatment because a medical professional did not take them seriously. Stigma
was also widespread within families and in social situations. Forty-nine percent said that
their families sometimes make them feel that they exaggerate their condition and, sadly,
32% of respondents with children have been made to feel that they are inadequate parents.
Almost half of respondents who lived with a neurological disorder during childhood found
it difficult to make friends or maintain friendships at school, and a similar number were
excluded from school events on account of their condition [60].
Finally, in an Australian survey of 1055 people with ME, 70% expressed a wish for
better-informed GPs, and 48% of respondents said their GPs were poorly or very poorly
informed, compared with 44% in 2015. Only 29% of respondents stated that their GPs were
well or very well informed, and only 31% regarded health professionals as a key source of
information about ME/CFS [61].
The quantitative studies of GP attitudes in the U.K., which demonstrated a con-
siderable degree of scepticism about ME/CFS, were undertaken in the aftermath of the
publication of the report of the U.K. Chief Medical Officer’s working party on ME/CFS,
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which had confirmed its existence as a genuine clinical entity [62]. This suggests that
the impact of that report on a substantial body of medical opinion was minimal, which
is disappointing. The qualitative studies, and studies involving patients, from a wider
time scale and range of geographical locations, suggest that such attitudes are by no means
confined to the U.K., and remain widespread. The lack of undergraduate and postgraduate
teaching on ME/CFS for medical students and doctors may account in large measure for the
persistence of such attitudes, and, in a parallel study, we have investigated the current status
of medical education on ME/CFS across Europe, as well as possible solutions to the problem.
5. Conclusions
Between a third and a half of GPs lack confidence in diagnosing or managing ME/CFS,
or dispute its existence as a genuine clinical entity. A similar proportion of ME/CFS patients
express dissatisfaction with the primary medical care they have received, and experienced
marked diagnostic delay when they first fell ill. These proportions have changed little over
recent years, and similar conclusions have been reached across the range of geographical
locations where these matters have been investigated. This conclusion renders problematic
attempts to determine the prevalence of ME/CFS, and hence its economic impact. In
addition, diagnostic delay is associated with severe disease and poor prognosis, and the
likelihood of increased costs.
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